Bio-Rad Laboratories, Inc.
Medtech firm with $17M federal contracts across DoD/HHS/VA and small Trump stock holding, but zero lobbying and no recent political trades.
BusinessWhat BIO does
Bio-Rad Laboratories, Inc. (BIO) develops and manufactures medical devices and life science research products in the healthcare sector, securing revenue from device sales and holding 496 federal contracts totaling $17.2M obligations from agencies including Department of Defense, Department of Health and Human Services, and Department of Veterans Affairs per get_government_precedent.
12 months past · 3 months futureBIO activity timeline
Executive Branch ConflictsBIO held by Trump-administration officials
Lifetime Government AwardsBIO federal contracts by year
Congressional TradesWho in Congress is trading BIO
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Political ProfileWhere BIO sits in Washington
Trump holds BIO Class A common stock ($1,001-$15,000 dividends) per get_executive_branch_exposure and $17.2M federal contract obligations per get_government_precedent, but zero influence score per get_political_influence, no insider clusters per get_corporate_insider_signal, and no congressional trades since 2024 per get_sector_political_positioning.
Regulatory ExposureThreats & opportunities
Regulatory threats
- No specific regulatory threats flagged.
Regulatory opportunities
- Federal contracts with Department of Defense, HHS, VA per get_government_precedent
Live signals + predictions for BIO — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades BIO
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord